Fortis Malar Hospitals Ltd
Incorporated in 1992, Fortis Malar Hospital Ltd is in the business of setting up, managing, and operating a multi-speciality hospital.[1]
- Market Cap ₹ 103 Cr.
- Current Price ₹ 54.7
- High / Low ₹ 78.6 / 40.8
- Stock P/E 24.4
- Book Value ₹ 18.2
- Dividend Yield 0.00 %
- ROCE 14.9 %
- ROE 13.1 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Stock is trading at 3.00 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of -0.73% over last 3 years.
- Earnings include an other income of Rs.6.30 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117.93 | 129.61 | 140.56 | 149.19 | 144.59 | 111.87 | 69.24 | 86.18 | 85.95 | 59.01 | 0.00 | 0.00 | |
| 110.39 | 123.33 | 139.66 | 147.47 | 146.94 | 114.52 | 75.56 | 82.72 | 81.37 | 60.20 | 2.12 | 1.51 | |
| Operating Profit | 7.54 | 6.28 | 0.90 | 1.72 | -2.35 | -2.65 | -6.32 | 3.46 | 4.58 | -1.19 | -2.12 | -1.51 |
| OPM % | 6.39% | 4.85% | 0.64% | 1.15% | -1.63% | -2.37% | -9.13% | 4.01% | 5.33% | -2.02% | ||
| 7.35 | 6.95 | 7.54 | 8.18 | 9.60 | 10.84 | 14.93 | 7.33 | 6.56 | 66.80 | 2.72 | 6.30 | |
| Interest | 0.51 | 0.40 | 0.46 | 0.38 | 0.51 | 7.81 | 7.20 | 6.56 | 6.07 | 4.30 | 0.01 | 0.00 |
| Depreciation | 2.71 | 3.16 | 3.94 | 4.21 | 4.38 | 12.53 | 12.88 | 12.53 | 12.15 | 9.36 | 0.00 | 0.00 |
| Profit before tax | 11.67 | 9.67 | 4.04 | 5.31 | 2.36 | -12.15 | -11.47 | -8.30 | -7.08 | 51.95 | 0.59 | 4.79 |
| Tax % | 34.36% | 35.68% | 29.95% | 40.87% | 26.69% | -25.51% | -30.08% | 0.00% | 119.49% | 8.99% | 30.51% | 12.32% |
| 7.66 | 6.23 | 2.82 | 3.14 | 1.74 | -9.06 | -8.01 | -8.31 | -15.53 | 47.28 | 0.41 | 4.20 | |
| EPS in Rs | 4.12 | 3.35 | 1.51 | 1.68 | 0.93 | -4.83 | -4.27 | -4.43 | -8.29 | 25.23 | 0.22 | 2.24 |
| Dividend Payout % | 12.15% | 14.94% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 168.63% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -5% |
| 5 Years: | 18% |
| 3 Years: | 31% |
| TTM: | 924% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -4% |
| 3 Years: | 4% |
| 1 Year: | -28% |
| Return on Equity | |
|---|---|
| 10 Years: | -5% |
| 5 Years: | -7% |
| 3 Years: | -1% |
| Last Year: | 13% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 18.61 | 18.62 | 18.68 | 18.70 | 18.76 | 18.76 | 18.76 | 18.76 | 18.76 | 18.76 | 18.76 | 18.76 |
| Reserves | 71.85 | 78.05 | 79.60 | 82.90 | 84.84 | 75.67 | 67.86 | 59.21 | 43.20 | 90.45 | 11.21 | 15.41 |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 64.34 | 57.17 | 53.41 | 46.40 | 0.00 | 0.00 | 0.00 | |
| 19.48 | 32.36 | 30.83 | 45.74 | 44.90 | 32.64 | 23.20 | 27.30 | 27.33 | 6.18 | 6.60 | 2.80 | |
| Total Liabilities | 109.94 | 129.03 | 129.11 | 147.34 | 148.50 | 191.41 | 166.99 | 158.68 | 135.69 | 115.39 | 36.57 | 36.97 |
| 17.71 | 24.50 | 24.59 | 23.79 | 21.85 | 81.08 | 68.52 | 57.62 | 47.41 | 0.00 | 0.00 | 0.00 | |
| CWIP | 0.64 | 0.36 | 0.61 | 0.72 | 0.73 | 0.09 | 0.36 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
| 91.54 | 104.12 | 103.86 | 122.78 | 125.87 | 110.19 | 98.06 | 100.95 | 88.23 | 115.34 | 36.52 | 36.92 | |
| Total Assets | 109.94 | 129.03 | 129.11 | 147.34 | 148.50 | 191.41 | 166.99 | 158.68 | 135.69 | 115.39 | 36.57 | 36.97 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.18 | 10.70 | -10.34 | 9.75 | -15.73 | -0.27 | -1.20 | 6.80 | 5.61 | -7.21 | 1.77 | 0.28 | |
| 5.23 | -22.00 | 15.18 | -2.29 | 6.11 | 48.31 | -27.60 | 8.18 | 0.43 | 119.62 | -27.30 | 0.46 | |
| 0.00 | -1.09 | -0.97 | 0.05 | 0.15 | -11.57 | -7.25 | -10.10 | -12.65 | -10.85 | -79.65 | 0.00 | |
| Net Cash Flow | 9.41 | -12.39 | 3.88 | 7.51 | -9.47 | 36.47 | -36.05 | 4.87 | -6.61 | 101.56 | -105.18 | 0.74 |
| Free Cash Flow | 0.79 | 0.13 | -13.90 | 6.07 | -18.44 | -3.17 | -1.73 | 5.52 | 3.73 | -9.51 | 1.77 | 0.28 |
| CFO/OP | 130% | 235% | -226% | 830% | 477% | -164% | 203% | 216% | 120% | 186% | 71% | 79% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 13.03 | 16.93 | 14.49 | 14.68 | 24.39 | 12.17 | 11.02 | 9.32 | 13.50 | 0.00 | ||
| Inventory Days | 13.24 | 35.39 | 28.37 | 22.30 | 18.04 | 22.44 | 42.32 | 39.89 | 31.71 | 0.00 | ||
| Days Payable | 169.12 | 286.36 | 172.55 | 275.68 | 254.81 | 323.38 | 374.86 | 428.69 | 584.12 | |||
| Cash Conversion Cycle | -142.85 | -234.05 | -129.69 | -238.70 | -212.39 | -288.77 | -321.53 | -379.49 | -538.90 | 0.00 | ||
| Working Capital Days | 165.77 | 127.49 | 149.75 | 129.52 | 153.66 | -54.62 | 114.34 | 21.81 | 184.09 | 4.21 | ||
| ROCE % | 13.96% | 11.64% | 4.64% | 5.69% | 2.88% | -3.25% | -7.35% | -1.30% | -0.84% | -1.54% | 0.86% | 14.94% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALOS (Average Length of Stay) Days |
|
||||||||||
| ARPOB (Average Revenue Per Occupied Bed) INR Lakhs |
|||||||||||
| Occupancy Rate % |
|||||||||||
| Total Bed Capacity Number |
|||||||||||
| IPD Admissions Number |
|||||||||||
| OPD Patients Number |
|||||||||||
| Surgeries Conducted Number |
|||||||||||
Extracted by Screener AI
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 19 May
-
Modification In The Policy For The Determination Of Materiality Of Events/Information, Which Also Contains The Details Of Persons Authorized To Determine The Materiality Of The Event/Information For The Purpose Of Disclosures To Stock Exchange
18 May - Board approved FY26 audited standalone and consolidated results, unmodified auditor opinion, and revised materiality and insider trading policies.
-
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
18 May - Board approved FY26 audited standalone and consolidated results; auditors issued unmodified opinion; policies updated.
-
Board Meeting Outcome for Outcome Of Board Meeting - 18.05.2026
18 May - Board approved FY26 audited standalone and consolidated results on May 18, 2026; auditors issued unmodified opinion.
- Audited Financial Results For The Quarter And Year Ended March 31, 2026 18 May
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
FMHL is a subsidiary of Fortis Hospitals Limited. The company used to run a multi-speciality hospital facility in Chennai. The hospital building
was owned by a fellow subsidiary, Fortis Health Management Limited. The Parent Company has 1 wholly owned subsidiary company, Malar Stars Medicare Limited